Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
332.92
-2.14 (-0.64%)
Sep 30, 2026, 3:09 PM EDT - Market open
Krystal Biotech Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Buy Initiates $441 | Buy | Initiates | $441 | +32.46% | Sep 24, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $392 → $400 | Buy | Reiterates | $392 → $400 | +20.15% | Sep 21, 2026 |
| RBC Capital | RBC Capital | Buy Initiates $400 | Buy | Initiates | $400 | +20.15% | Aug 14, 2026 |
| Wolfe Research | Wolfe Research | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 12, 2026 |
| Citi | Citi | Buy Maintains $378 → $386 | Buy | Maintains | $378 → $386 | +15.94% | Aug 4, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $403 | Buy | Maintains | $403 | +21.05% | Aug 4, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $361 | Buy | Reiterates | $361 | +8.43% | Aug 3, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 3, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.